ELYM - Eliem Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $6.13. This is a potential upside of $3.04 (98.38%) from yesterday's end of day stock price of $3.09.

Eliem Therapeutics's activity chart (see below) currently has 2 price targets and 3 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.58% with an average time for these price targets to be met of 316.25 days.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 08-Mar-2023. First documented stock forecast 07-Sep-2021.

Best performing analysts who are covering ELYM - Eliem Therapeutics:

Douglas Tsao Marc Goodman Paul Matteis Yatin Suneja

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$6

$2.91 (94.17%)

2 years 1 months 28 days ago
(08-Mar-2023)

2/2 (100%)

$2.36 (64.84%)

485

Buy

$4

$0.91 (29.45%)

$13

2 years 8 months 20 days ago
(16-Aug-2022)

1/4 (25%)

$1.11 (38.41%)

141

Buy

$8

$4.91 (158.90%)

2 years 9 months 4 days ago
(02-Aug-2022)

1/3 (33.33%)

$5.28 (194.12%)

639

Hold

$32

3 years 10 days ago
(26-Apr-2022)

0/1 (0%)

$3.39 (11.85%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ELYM (Eliem Therapeutics) average time for price targets to be met?

On average it took 316.25 days on average for the stock forecasts to be realized with a an average price target met ratio 39.58

Which analyst has the current highest performing score on ELYM (Eliem Therapeutics) with a proven track record?

DOUGLAS TSAO

Which analyst has the current lower performing score on ELYM (Eliem Therapeutics) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on ELYM (Eliem Therapeutics)?

Douglas Tsao has 3 price targets and 3 ratings on ELYM

Which analyst is the currently most bullish on ELYM (Eliem Therapeutics)?

Paul Matteis with highest potential upside - $4.91

Which analyst is the currently most reserved on ELYM (Eliem Therapeutics)?

Yatin Suneja with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?